Login
← Go Back
Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024
Stock Price vs Company Growth
1d
4.3%
1w
5.4%
1m
13.1%
3m
11.4%
all
1.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 757 4.3%
635
794
Company Overview
Sales
1,842 Cr
Growth: 14.8%
Profit after Tax
238 Cr
Growth: 25.7%
Mid Cap
15,782 Cr
P/E: 61.9x
Industry P/E: 32.8x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 1,842
Growth 14.8%
EBITDA 27.1%
P/S 8.6x
Dividend 0.0%
P/E 61.9x
Book Value ₹ 102
PEG Ratio 4.2x
ROE 22.9%
P/B 7.4x
Shareholding Pattern
Increase    Decrease    No change
Company Profile Detailed
The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Belongs to (13 Indices) view more
Followers (1)
varsha96